| Brynn Charlotte Krukemyer, PA-C | |
|
900 W South Boundary St, Perrysburg, OH 43551-5230 | |
| (419) 873-6963 | |
| Not Available |
| Full Name | Brynn Charlotte Krukemyer |
|---|---|
| Gender | Female |
| Speciality | Dermatology - Procedural Dermatology |
| Location | 900 W South Boundary St, Perrysburg, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861083008 | NPI | - | NPPES |
| 50.006703RX | Other | OH | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207NS0135X | Dermatology - Procedural Dermatology | 50.006703 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brynn Charlotte Krukemyer, PA-C 506 West St, Genoa, OH 43430 Ph: (419) 708-8012 | Brynn Charlotte Krukemyer, PA-C 900 W South Boundary St, Perrysburg, OH 43551-5230 Ph: (419) 873-6963 |
News Archive
Doctors have their first FDA-approved tool to treat drug-resistant HIV thanks to a new molecule created by a Purdue University researcher.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will present final data from a Phase 2a trial showing that miravirsen given as a four-week monotherapy treatment provided robust dose-dependent anti-viral activity with a mean reduction of 2 to 3 logs from baseline in HCV RNA (log10 IU/mL) that was sustained well beyond the end of therapy.
Cardinal Health today announced plans to acquire Kinray, Inc., a leading pharmaceutical distributor serving the New York metropolitan area, for $1.3 billion in an all-cash transaction that will significantly expand its ability to serve retail independent pharmacies in the northeastern United States.
Sen. Chuck Grassley (R-Iowa) has sent a letter to Merck Chief Operating Officer Richard Clark requesting the company explain a recent report that found the company used employees or paid consultants rather than the physicians listed as lead authors to write several published studies of the COX-2 inhibitor Vioxx, CQ HealthBeat reports.
A new study published as "Editor's Choice" in The Journal of Infectious Diseases found that expansion of HIV treatment eligibility to include those under age 15 led to large and significant increases in initiation of antiretroviral therapy within 30 days of enrollment in care among 10- to 14-year-olds living with HIV.
› Verified 5 days ago
Dr. Hope Terecia Mitchell, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 815 Commerce Dr, Perrysburg, OH 43551 Phone: 419-871-3737 Fax: 419-873-8329 | |
Dr. Beth Ann Zavell, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12780 Roachton Road, #1, Perrysburg, OH 43551 Phone: 419-872-0777 Fax: 419-872-2369 | |
Dr. Sarah Campbell Stierman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12780 Roachton Rd # 1, Perrysburg, OH 43551 Phone: 419-872-0777 | |
Dana Lynn Sachs, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12780 Roachton Rd, Perrysburg, OH 43551 Phone: 419-872-0777 | |
Dr. Christy Ann Lorton, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12780 Roachton Rd #1, Perrysburg, OH 43551 Phone: 419-872-0777 Fax: 419-872-2369 | |
Dr. Abdel Kader Tal, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 900 W South Boundary St Bldg 9a, Perrysburg, OH 43551 Phone: 419-873-6963 Fax: 419-873-6964 |